Occudo Quantitative Strategies LP Amneal Pharmaceuticals, Inc. Transaction History

Occudo Quantitative Strategies LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$5.36 - $7.11 $670 - $888	-125 Reduced 0.28%	45,150 $286,000
Q1 2024 May 15, 2024	BUY	$5.24 - $6.34 $237,241 - $287,043	45,275 New	45,275 $274,000
Q3 2023 Nov 14, 2023	SELL	$2.76 - $4.59 $238,886 - $397,278	-86,553 Reduced 71.87%	33,883 $142,000
Q2 2023 Aug 14, 2023	BUY	$1.33 - $3.1 $2,199 - $5,127	1,654 Added 1.39%	120,436 $373,000
Q1 2023 May 15, 2023	BUY	$1.27 - $2.7 $72,734 - $154,631	57,271 Added 93.11%	118,782 $165,000
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $50,005 - $66,588	25,513 Added 70.87%	61,511 $122,000
Q3 2022 Nov 14, 2022	BUY	$2.02 - $3.62 $72,715 - $130,312	35,998 New	35,998 $73,000
Q3 2021 Nov 15, 2021	SELL	$4.31 - $5.64 $137,458 - $179,876	-31,893 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$5.12 - $6.82 $42,347 - $56,408	-8,271 Reduced 20.59%	31,893 $163,000
Q1 2021 May 14, 2021	BUY	$4.74 - $7.38 $190,377 - $296,410	40,164 New	40,164 $270,000

184

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.19B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.